On the 20th March 2012, Dr David Wadsworth will be presenting on medicinal chemistry outsourcing atDrug Discovery World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012, held at Marina Bay Sands, Singapore.
Dr Wadsworth carried out his Ph.D work at Imperial College, London, joining Ciba-Geigy in Basel as a Research Chemist in 1989. After taking on additional responsibilities in the area of managing external collaborations and compound acquisition, he took on an 18 month assignment at the Novartis research facility in Sydney, Australia. On returning to Switzerland he held a number of positions within the Novartis global research informatics organisation. In 2001 David joined Roche as the Research Informatics Site Head for Basel, and in 2005 he moved to the Safety & Technical Sciences organisation where he was responsible for the Basel operations. In 2007, David returned to medicinal chemistry, taking up the global responsibility for outsourcing and operations. The majority of the Roche Pharma-managed outsourced medicinal chemistry activities take place in Asia.
Here are some of the points that Dr Wadsworth will be sharing with us:
1. Exploring what parts of medicinal chemistry should be outsourced and where and how should this be done
2. Parameters to measure success of outsourcing activities
3. Current perspectives on the future of outsourcing in Asia